Skip to search formSkip to main contentSkip to account menu

3 ML liraglutide 6 MG/ML Pen Injector [Saxenda]

Known as: LIRAGLUTIDE (SAXENDA) 6MG/ML INJ PEN 3ML, Saxenda 18 MG per 3 ML Pen Injector, Saxenda 6 MG/ML in 3 mL Pen Injector 
National Institutes of Health

Related topics

Related topics

9 relations
Glucagon-Like Peptide 1Pen InjectorPropylene glycolSaxenda

Broader (1)

liraglutide Pen Injector [Saxenda]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Saxenda® Frenzy: Opinions of an Endocrine and Metabolism Specialist
Corresponding author: Sungrae Kim Division of Endocrine and Metabolism, The Catholic University of Korea, Bucheon St. Mary’s… 
2018
2018
Liraglutid in der Pharmakotherapie der Adipositas
Aufgrund der weltweit zunehmenden Pravalenz von Ubergewicht und Adipositas gewinnen medikamentose Therapien zur Gewichtsreduktion… 
2016
2016
GLP-1-Analogon zur Gewichtsreduktion
Hintergrund. In derTherapie des Diabetesmellitus Typ 2 werden „Glucagon-like peptide-1“-(GLP-1-)Analoga bereits seit ed des unter… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)